Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies
NCT00389480
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Tumors
Interventions
DRUG:
AR-67 (formerly DB-67)
Sponsor
Arno Therapeutics
Collaborators
[object Object]
[object Object]